Methods and compositions for inhibiting angiogenesis
The present invention provides a method of inhibiting angiogenesis within a tissue by providing exogenous PEDF to cells associated with the tissue. The presence of exogenous PEDF inhibits angiogenesis within the tissue, in part by interfering with the ability of vascular endothelia to expand within the tissue. The invention also provides a method for determining the severity of a tumor be assaying for the presence of PEDF within the tumor. To facilitate the inventive methods, the present invention provides pharmaceutical compositions including sources of PEDF.
1. A method of inhibiting the growth of a neuroblastoma tumor in a subject, said method comprising administering to the subject an effective amount of cells isolated from said subject which have been transfected ex vivo with an expression vector comprising a nucleic acid encoding PEDF or a biologically active fragment of PEDF, wherein the amount of PEDF secreted by the population of cells is effective to inhibit growth of endothelial cells in the neuroblastoma tumor.
2. The method of claim 1 , wherein said PEDF is encoded by an isolated nucleic acid comprising SEQ ID NO: 2.
3. The method of claim 2 , wherein said PEDF is encoded by an isolated nucleic acid consisting of SEQ ID NO: 2.
4. The method of claim 1 , wherein said biologically active fragment of PEDF is contained within the amino acid sequence of SEQ ID NO: 1.
5. The method of claim 4 , wherein said biologically active fragment of PEDF comprises amino acids 44 to 121 of SEQ ID NO: 1.
6. The method of claim 4 , wherein said biologically active fragment comprises amino acids 44 to 77 of SEQ ID NO: 1.
7. The method of claim 1 , wherein the PEDF comprises the amino acid sequence of SEQ ID NO: 1.
8. The method of claim 1 , wherein the PEDF consists of the amino acid sequence of SEQ ID NO: 1.
9. The method of claim 1 , wherein the subject is human.